ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2001

Survivin Controls the Transcriptional Activity by Changing the Pattern of Histone H3 Marks on Chromatin

Karin Andersson 1, Malin Erlandsson 1, Anastasius Damdimopoulos 2, Robin Bremer 1, Maja Jensen 3, Maria-José Garcia-Bonete 3, Gergely Katona 3 and Maria Bokarewa1, 1Department of Rheumatology and Inflammation Research, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden, 2Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden, Stockholm, Sweden, 3Department of Chemistry and Molecular Biology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Autoimmunity, Epigenetics, histon methylation and CD4 T cells, survivin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The oncoprotein survivin coded by the BIRC5 gene was described as an important marker in rheumatoid arthritis (RA). Survivin participates in cell division being a member of the chromosomal passenger complex, while its role in gene transcription remains unknown. The purpose of this study was to identify survivin-specific transcription pattern in CD4+ T-cells.

Methods: CD4+ T cells of RA patients and healthy females were isolated from the perpheral blood, activated and treated with a survivin inhibitor YM155. Chromatin was immunoprecipitated using polyclonal antibodies to survivin and to histone H3 trimethylation H3K27me3, H3K4me3 and acetylation H3K27ac marks. DNA libraries were prepared for all ChIP material using ThruPLEX (Rubicon) and high throughput sequencing was performed using Hiseq2000 (Illumina) and aligned to the human reference genome (Ensembl GRCh38) using the STAR aligner. Transcriptional analysis was done by RNAseq (Illumina) and conventional qPCR.

Results: Genome-wide analysis of survivin binding to chromatin in activated primary CD4+ T cells was enriched (p< 10-5) and annotated to RNA polymerase II-specific DNA binding transcription factor activity (GO:0000981) with known roles in developmental processes (GO:0032502), and cell communication (GO:0010646, GO:0098742). A search in the ENDCODE ChIP database identified colocalization of survivin with the enhancer of zeste homolog 2 (FDR< 10-33) and Suz12 (FDR< 0.001%), the subunits of the Polycomb-repressive complex 2 responsible for the trimethylation of H3K27. The analysis of histone H3 bound chromatin in CD4 cells revealed colocalisation of H3K27ac, H3K27me3 and H3K4me3 marks to 3784 common peaks. A surplus of the activation marks H3K4me3 and H3K27ac was found in 74%, while 25.6% genes had a surplus of the repressive mark H3K27me3, which was in agreement with the activated cell phenotype. Alignment of survivin peaks with histone H3 marks revealed a co-localization of survinin-ChIP with H3K27me3 (82.7%) mark rather than H3K4me3 (66%) (p=0.042). Depletion of survivin in cultured CD4 cells resulted in a significant general increase in deposition of the repressive H3K27me3 mark on chromatin (FC 1.98; p< 10-24) and shifted a balance from H3K27ac and H3K4me3 marks. Only 4% of the H3K4me3 surplus peaks kept it after survivin depletion. mRNA analysis of CD4 cells showed that survivin depletion changed the transcription of the genes controlled by H3K27me3 and EZH2. Among those we found the the genes of HOX-B cluster and their partners MEIS, PKNOX and PBX1 controlling the development of anatomical structures including joints.

Conclusion: This genome-wide study suggest that survivin has important transcription regulating function. It preserves optimal levels of the repressive histone H3K27me3 mark with a potential impact on the function of HOX genes and limb pathology in RA patients.


Disclosure: K. Andersson, None; M. Erlandsson, None; A. Damdimopoulos, None; R. Bremer, None; M. Jensen, None; M. Garcia-Bonete, None; G. Katona, None; M. Bokarewa, None.

To cite this abstract in AMA style:

Andersson K, Erlandsson M, Damdimopoulos A, Bremer R, Jensen M, Garcia-Bonete M, Katona G, Bokarewa M. Survivin Controls the Transcriptional Activity by Changing the Pattern of Histone H3 Marks on Chromatin [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/survivin-controls-the-transcriptional-activity-by-changing-the-pattern-of-histone-h3-marks-on-chromatin/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/survivin-controls-the-transcriptional-activity-by-changing-the-pattern-of-histone-h3-marks-on-chromatin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology